<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350667</id>
  <title nil="true"/>
  <common-name>N,n-diphenyl-2-[4-[(e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl]acetamide</common-name>
  <description>N,n-diphenyl-2-[4-[(e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl]acetamide is a chemical compound with the formula C30H33N3O5. With an average molecular weight of 515.60 g/mol, N,n-diphenyl-2-[4-[(e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl]acetamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>6445273</pubchem-id>
  <chemical-formula>C30H33N3O5</chemical-formula>
  <weight>515.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:52:38Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:52:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCN(CC2)CC(=O)N(C3=CC=CC=C3)C4=CC=CC=C4</moldb-smiles>
  <moldb-formula>C30H33N3O5</moldb-formula>
  <moldb-inchi>InChI=1S/C30H33N3O5/c1-36-26-20-23(21-27(37-2)30(26)38-3)14-15-28(34)32-18-16-31(17-19-32)22-29(35)33(24-10-6-4-7-11-24)25-12-8-5-9-13-25/h4-15,20-21H,16-19,22H2,1-3H3/b15-14+</moldb-inchi>
  <moldb-inchikey>IPQJSMAHFVSALH-CCEZHUSRSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">515.2420212</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346560</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N,n-diphenyl-2-[4-[(e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Phenylpropanoids and polyketides</superklass>
  <klass>Cinnamic acids and derivatives</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300972</sync-id>
  <structure-inchikey>IPQJSMAHFVSALH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>1000000000020800000000000000000000000000000000000000000400000042080000000000400000000000004200000000000000000000000000000000000000000000000000000000000000020000008000300000000001000000000000000010000001040000400104100000000020100000004000000000000000000000040000000808000000000000000000000000100000000020000000000000000088000000000000000080000000000000080000000088000000000000080000000000004010000000000000004000000000000000000000200000000010000000008000000000040000800008400000000000020000000004000004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:40Z</structure-indexed-at>
</compound>
